Buckingham Strategic Wealth’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Buckingham Strategic Wealth's BIIB Position: Q1 2021 in Review
Buckingham Strategic Wealth sold out of Biogen (BIIB) in Q1 2021, closing a stake of 1,159 shares — an estimated $284K sold.
Buckingham Strategic Wealth first reported a position in BIIB in Q1 2014 and held it in 18 quarters. The position peaked at $394K in Q1 2019. 1,094 funds tracked by Wall St. Rank hold BIIB as of Q1 2021.
- Buckingham Strategic Wealth reported no remaining Biogen position as of Q1 2021 after selling out during the quarter.
- Buckingham Strategic Wealth sold 1,159 Biogen shares in Q1 2021, an estimated $284K.
- Buckingham Strategic Wealth first reported a position in Biogen in Q1 2014 and held it in 18 quarters.
- Buckingham Strategic Wealth's Biogen position peaked at $394K in Q1 2019.
- 1,094 funds tracked by Wall St. Rank held Biogen as of Q1 2021.
Based on Buckingham Strategic Wealth's 13F filing for Q1 2021, filed 30 Apr 2021.